ММВБ 3 837 0,4%  Nasdaq 14 272 0,1%  Биткойн 32 596 -3,1%  USD/RUB 72,5595 -0,1% 
РТС 1 666 1,3%  S&P500 4 242 -0,1%  Нефть 75,2 -0,3%  EUR/RUB 86,5110 -0,1% 
Dow 33 874 -0,2%  FTSE100 7 074 -0,2%  Золото 1 776 -0,2%  EUR/USD 1,1924 0,0% 

Veracyte Inc - Профиль

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Акционеры

Название Доля (%)
Freefloat98,84
ARK Investment Management LLC14,02
ARK Investment Management LLC11,37
Vanguard Group, Inc. (Subfiler)9,30
The Vanguard Group, Inc.7,35
Artisan Partners Holdings LP7,00
William Blair Investment Management LLC6,86
Artisan Partners LP6,10
Invesco Advisers, Inc.5,99
Nikko Asset Management Americas, Inc.5,65
ARK Innovation ETF5,39
Nikko AM Global Umbrella Fund - ARK Disruptive Innovation4,92
Nikko Asset Management Americas, Inc.4,91
Matrix Capital Management Co. LP4,44
BlackRock Fund Advisors4,44

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент